Chile is among the most successful nations worldwide in terms of its COVID-19 vaccine rollout. By 31 December 2021, 84.1% of the population was fully vaccinated, and 56.1% received booster doses using different COVID-19 vaccines. In this context, we aimed to estimate the prevalence of anti-SARS-CoV-2 antibodies following the infection and vaccination campaign. Using a three-stage stratified sampling, we performed a population-based cross-sectional serosurvey based on a representative sample of three Chilean cities. Selected participants were blood-sampled on-site and answered a short COVID-19 and vaccination history questionnaire using Wantai SARS-CoV-2 Ab ELISA to determine seroprevalence. We recruited 2198 individuals aged 7–93 between 5 October and 25 November 2021; 2132 individuals received COVID-19 vaccinations (97%), 67 (3.1%) received one dose, 2065 (93.9%) received two doses, and 936 received the booster jab (42.6%). Antibody seroprevalence reached 97.3%, ranging from 40.9% among those not vaccinated to 99.8% in those with booster doses (OR = 674.6, 154.8–2938.5). SARS-CoV-2 antibodies were associated with vaccination, previous COVID-19 diagnosis, age group, and city of residence. In contrast, we found no significant differences in the type of vaccine used, education, nationality, or type of health insurance. We found a seroprevalence close to 100%, primarily due to the successful vaccination program, which strongly emphasizes universal access.
Using levels of neutralizing antibodies (nAbs), we evaluate the successful Chilean SARS-CoV-2 vaccine campaign, which combines different vaccine technologies and heterologous boosters. From a population-based study performed in November 2021, we randomly selected 120 seropositive individuals, organized into six groups of positive samples (20 subjects each) according to natural infection history and the five most frequent vaccination schemes. We conclude that the booster dose, regardless of vaccine technology or natural infection, and mRNA vaccines significantly improve nAbs response.
Introduction: Hemodialysis produces an alteration of the daily activities of people with chronic kidney disease that significantly impair their quality of life. How these people represent their condition affects the control of disease and quality of life. Objective: To assess the association between illness representation and perception of quality of life in people with chronic kidney disease on hemodialysis. Methodology: predictive correlational cross-sectional study conducted in 100 patients with chronic kidney disease on hemodialysis. Were used as instruments the IPQ-R (representation of disease) and KDQOL-SF (measuring quality of life). We applied descriptive statistical, analytical and path analysis. Results: A higher score on the perception of specific quality of life was observed vs generic. In the representation of disease is observed that those who earn less signs and symptoms have fewer consequences (r = 0.317; p = 0.001), also, who identify less consequences have fewer psychological symptoms (r = 0.496; p = 0.000) and greater understanding of the disease (r = -0,428; p = 0.000). The relationship between quality of life and disease representing an inverse correlation between the perception of signs and symptoms (identity) and the perceived overall quality of life was found (r = - 403;. P = 0.000) and specific (r = -.380; p = 0.000). Discussion: It is important to consider the user's perception in evaluating the quality of life and the representation of disease, to promote their empowerment regarding their disease.
Objective: To explore the experience and perception of international migrants in Chile regarding access to health services during the pandemic. Method: Collective case study following the qualitative paradigm. Forty semi-structured interviews were carried out with 30 migrants from different countries in Latin America and the Caribbean and 10 key actors from the health or social sector in November and December 2020. The interviews were analyzed thematically. Results: Perceived facilitators for general access to health services are related to formal work, support networks, and good treatment, while barriers are linked to immigration status, information gaps, discrimination, lack of cross-cultural skills, and personal limits of the system. In the context of access to COVID-19 diagnosis and treatment, the main barriers identified are: cultural approach to the disease, communication gaps, experiences of discrimination, costs, and lack of support networks. Conclusion: Access to health services is related to social vulnerability and violation of international migrants rights.